HOME › DRUGS › AUTOLOGOUS CD34+ ENRICHED CELL FRACTION THAT CONTAINS CD34+ CELLS TRANSDUCED WITH RETROVIRAL VECTOR THAT ENCODES FOR THE HUMAN ADA CDNA SEQUENCE
ACTIVE SUBSTANCE / INN

AUTOLOGOUS CD34+ ENRICHED CELL FRACTION THAT CONTAINS CD34+ CELLS TRANSDUCED WITH RETROVIRAL VECTOR THAT ENCODES FOR THE HUMAN ADA CDNA SEQUENCE

Brand name(s): Strimvelis
EMA LISTED
AUTHORISED
Severe Combined Immunodeficiency
ACTIVE SUBSTANCE
Autologous Cd34+ Enriched Cell Fraction That Contains Cd34+ Cells Transduced With Retroviral Vector That Encodes For The Human Ada Cdna Sequence
REGULATORS
EMA
SPONSORS / MAH
Fondazione Telethon ETS
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
StrimvelisFondazione Telethon ETSAuthorised26/05/2016Severe Combined Immunodeficiency

FULL INTELLIGENCE ON AUTOLOGOUS CD34+ ENRICHED CELL FRACTION THAT CONTAINS CD34+ CELLS TRANSDUCED WITH RETROVIRAL VECTOR THAT ENCODES FOR THE HUMAN ADA CDNA SEQUENCE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →